Cargando…

Hyperinflammation, T cells, and endotoxemia

Detalles Bibliográficos
Autores principales:	Inoue, Makoto, Shinohara, Mari L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695100/ https://www.ncbi.nlm.nih.gov/pubmed/26309079

Ejemplares similares

Sphingosine kinase-1 mediates endotoxemia-induced hyperinflammation in aged animals
por: LUFRANO, MARIA, et al.
Publicado: (2013)

Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors
por: Gasparyan, Armen Yuri, et al.
Publicado: (2022)

Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021)

Kawasaki-Erkrankung oder Hyperinflammations-Syndrom?
Publicado: (2020)

Kawasaki-Erkrankung oder Hyperinflammations-Syndrom?
por: -, -
Publicado: (2020)

Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022)

Current Concepts of Hyperinflammation in Chronic Granulomatous Disease
por: Rieber, Nikolaus, et al.
Publicado: (2012)

COVID-19 Hyperinflammation: What about Neutrophils?
por: Didangelos, Athanasios
Publicado: (2020)

Frontal encephalopathy related to hyperinflammation in COVID-19
por: Cani, Ilaria, et al.
Publicado: (2020)

Delving beneath the surface of hyperinflammation in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2020)

The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation
por: Chen, Jiezhong, et al.
Publicado: (2020)

Hyperinflammation with COVID-19: The key to patient deterioration?()()
por: Haigh, Kathryn, et al.
Publicado: (2020)

Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity?
por: Taha, Sara Ibrahim, et al.
Publicado: (2022)

Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis
por: Shapiro, Leland, et al.
Publicado: (2022)

Fostering experimental and computational synergy to modulate hyperinflammation
por: Potapov, Ilya, et al.
Publicado: (2022)

In Situ Neutralization and Detoxification of LPS to Attenuate Hyperinflammation
por: Li, Xiaoyu, et al.
Publicado: (2023)

Is the Intestine a Portal of Entry for the Serious COVID-19 Complications of Endotoxemia and Thrombosis?
por: Alpers, David H.
Publicado: (2021)

Endotoxemia is associated with an adverse metabolic profile
por: Määttä, Anne-Mari, et al.
Publicado: (2020)

Hyperinflammation bei SARS-CoV-2-Infektion
Publicado: (2020)

Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
por: Tanner, Tamara, et al.
Publicado: (2020)

IgGs drive COVID-19 myeloid hyperinflammation
por: Park, Matthew D.
Publicado: (2020)

Attenuating hyperinflammation in COVID-19: A change in paradigm?
por: Molnar, Zsolt, et al.
Publicado: (2020)

ACEi reduces hypertension-induced hyperinflammation in COVID-19
por: Lim, Gregory B.
Publicado: (2021)

Diagnostic Challenge and Therapeutic Approaches in Human Sepsis Based on the Appearance of Endotoxemia and Beta-d-Glucanemia
por: Tamura, Hiroshi, et al.
Publicado: (2021)

Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation
por: Heidel, F., et al.
Publicado: (2020)

Pseudomonas aeruginosa biofilm is a potent inducer of phagocyte hyperinflammation
por: Ciszek-Lenda, Marta, et al.
Publicado: (2019)

A nanotrap improves survival in severe sepsis by attenuating hyperinflammation
por: Shi, Changying, et al.
Publicado: (2020)

COVID‐19: lambda interferon against viral load and hyperinflammation
por: Andreakos, Evangelos, et al.
Publicado: (2020)

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
por: Ritchie, Andrew I, et al.
Publicado: (2020)

Endogenous oxidized phospholipids reprogram cellular metabolism and boost hyperinflammation
por: Gioia, Marco Di, et al.
Publicado: (2019)

Concurrent Immune Suppression and Hyperinflammation in Patients With Community-Acquired Pneumonia
por: Brands, Xanthe, et al.
Publicado: (2020)

Altered Cholesterol and Lipid Synthesis Mediates Hyperinflammation in COVID-19
por: Sohrabi, Yahya, et al.
Publicado: (2021)

The role of ibrutinib in COVID-19 hyperinflammation: A case report
por: Maynard, Suzanne, et al.
Publicado: (2021)

Tozinameran: Fulminant myocarditis and systemic hyperinflammation: 2 case reports
Publicado: (2021)

Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist
por: Papadopoulou, Charalampia, et al.
Publicado: (2020)

The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding
por: Rajsic, Sasa, et al.
Publicado: (2022)

NLRP3 Inflammasome and MS/EAE
por: Inoue, Makoto, et al.
Publicado: (2013)

Clustering of Pattern Recognition Receptors for Fungal Detection
por: Inoue, Makoto, et al.
Publicado: (2014)

Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19
por: Smeets, Tim J. L., et al.
Publicado: (2022)

A brewing storm: The neuropsychological sequelae of hyperinflammation due to COVID-19
por: Cothran, Thomas P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_la7956mi4r3o06a1v2b33r7opl